Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
In development
Reference number: GID-TA11096
Expected publication date: TBC
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in late September 2023 when we will write to stakeholders about how they can get involved.